These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20680247)

  • 1. A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice.
    Shibata K; Hashimoto T; Nobe K; Hasumi K; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):245-53. PubMed ID: 20680247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel embolic model of cerebral infarction and evaluation of Stachybotrys microspora triprenyl phenol-7 (SMTP-7), a novel fungal triprenyl phenol metabolite.
    Hashimoto T; Shibata K; Nobe K; Hasumi K; Honda K
    J Pharmacol Sci; 2010; 114(1):41-9. PubMed ID: 20703011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of a new series of SMTPs in the acetic acid-induced embolic cerebral infarct mouse model.
    Shibata K; Hashimoto T; Hasumi K; Honda K; Nobe K
    Eur J Pharmacol; 2018 Jan; 818():221-227. PubMed ID: 29107671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion.
    Miyazaki T; Kimura Y; Ohata H; Hashimoto T; Shibata K; Hasumi K; Honda K
    Stroke; 2011 Apr; 42(4):1097-104. PubMed ID: 21350203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.
    Ito A; Niizuma K; Shimizu H; Fujimura M; Hasumi K; Tominaga T
    Brain Res; 2014 Aug; 1578():38-48. PubMed ID: 25016287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of SMTP-7, a small-molecule anti-inflammatory thrombolytic, in embolic stroke in monkeys.
    Suzuki E; Nishimura N; Yoshikawa T; Kunikiyo Y; Hasegawa K; Hasumi K
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00448. PubMed ID: 30546909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Ischemia Reperfusion-Related Brain Hemorrhage by Stachybotrys Microspora Triprenyl Phenol-7 in Mice With Antioxidant Effects.
    Huang Y; Ohta Y; Shang J; Li X; Liu X; Shi X; Feng T; Yamashita T; Sato K; Takemoto M; Hishikawa N; Suzuki E; Hasumi K; Abe K
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3521-3528. PubMed ID: 30201460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gene expression in an embolic stroke model after thrombolysis with tissue plasminogen activator and Stachybotrys microspora triprenyl phenol-7.
    Hashimoto T; Shibata K; Ohata H; Hasumi K; Honda K
    J Pharmacol Sci; 2014; 125(1):99-106. PubMed ID: 24784876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineuroinflammatory Effect of SMTP-7 in Ischemic Mice.
    Huang Y; Ohta Y; Shang J; Morihara R; Nakano Y; Fukui Y; Liu X; Shi X; Feng T; Yamashita T; Sato K; Takemoto M; Hishikawa N; Suzuki E; Hasumi K; Abe K
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3084-3094. PubMed ID: 30078758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke.
    Hasumi K; Suzuki E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477998
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice.
    Shibata K; Hashimoto T; Nobe K; Hasumi K; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):103-8. PubMed ID: 21533990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.
    Akamatsu Y; Saito A; Fujimura M; Shimizu H; Mekawy M; Hasumi K; Tominaga T
    Neurosci Lett; 2011 Oct; 503(2):110-4. PubMed ID: 21871536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent efficacy of Stachybotrys microspora triprenyl phenol-7, a small molecule having anti-inflammatory and antioxidant activities, in a mouse model of acute kidney injury.
    Shibata K; Hashimoto T; Hasumi K; Nobe K
    Eur J Pharmacol; 2021 Nov; 910():174496. PubMed ID: 34506776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates.
    Sawada H; Nishimura N; Suzuki E; Zhuang J; Hasegawa K; Takamatsu H; Honda K; Hasumi K
    J Cereb Blood Flow Metab; 2014 Feb; 34(2):235-41. PubMed ID: 24192639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of SMTP-44D in mice stroke model in relation to neurovascular unit and trophic coupling.
    Shi X; Ohta Y; Shang J; Morihara R; Nakano Y; Fukui Y; Liu X; Feng T; Huang Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Suzuki E; Hasumi K; Abe K
    J Neurosci Res; 2018 Dec; 96(12):1887-1899. PubMed ID: 30242877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.
    Matsumoto N; Suzuki E; Ishikawa M; Shirafuji T; Hasumi K
    J Biol Chem; 2014 Dec; 289(52):35826-38. PubMed ID: 25361765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis.
    Hasumi K; Ohyama S; Kohyama T; Ohsaki Y; Takayasu R; Endo A
    J Antibiot (Tokyo); 1998 Dec; 51(12):1059-68. PubMed ID: 10048563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and absolute configuration of SMTP-0, a simplest congener of the SMTP family nonlysine-analog plasminogen modulators.
    Hasumi K; Hasegawa K; Kitano Y
    J Antibiot (Tokyo); 2007 Jul; 60(7):463-8. PubMed ID: 17721006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activities.
    Shinouchi R; Shibata K; Hashimoto T; Jono S; Hasumi K; Nobe K
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00648. PubMed ID: 33215875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure.
    Hu W; Ohyama S; Hasumi K
    J Antibiot (Tokyo); 2000 Mar; 53(3):241-7. PubMed ID: 10819294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.